ZNF461 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.332420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.843400E-01
Normal-vs-Stage2
1.020830E-01
Normal-vs-Stage3
1.902180E-02
Normal-vs-Stage4
5.311400E-01
Stage1-vs-Stage2
2.991800E-01
Stage1-vs-Stage3
1.292370E-01
Stage1-vs-Stage4
8.651800E-01
Stage2-vs-Stage3
1.133620E-01
Stage2-vs-Stage4
2.572400E-01
Stage3-vs-Stage4
1.140450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.333250E-01
Normal-vs-AfricanAmerican
9.985800E-02
Normal-vs-Asian
2.592400E-01
Caucasian-vs-AfricanAmerican
7.218000E-01
Caucasian-vs-Asian
8.558000E-01
AfricanAmerican-vs-Asian
8.767200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.508800E-01
Normal-vs-Female
1.173390E-01
Male-vs-Female
4.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.463600E-01
Normal-vs-Age(41-60Yrs)
2.446400E-01
Normal-vs-Age(61-80Yrs)
1.083580E-01
Normal-vs-Age(81-100Yrs)
1.079990E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.104400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.874400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.114300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.534200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.589840E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.406370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.405700E-02
Normal-vs-Daily Drinker
9.225600E-02
Normal-vs-Weekly Drinker
6.992500E-02
Normal-vs-Occasional Drinker
4.105400E-01
Normal-vs-Social Drinker
4.437000E-01
Non Drinker-vs-Daily Drinker
5.125000E-01
Non Drinker-vs-Weekly Drinker
5.680800E-01
Non Drinker-vs-Occasional Drinker
1.440210E-02
Non Drinker-vs-Social Drinker
2.377900E-02
Daily Drinker-vs-Weekly Drinker
9.749600E-01
Daily Drinker-vs-Occasional Drinker
1.036750E-01
Daily Drinker-vs-Social Drinker
1.339950E-01
Weekly Drinker-vs-Occasional Drinker
1.217040E-01
Weekly Drinker-vs-Social Drinker
1.526610E-01
Occasional Drinker-vs-Social Drinker
9.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.155500E-02
Normal-vs-Grade 2
1.020220E-02
Normal-vs-Grade 3
2.097600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.292600E-01
Grade 1-vs-Grade 3
6.403000E-01
Grade 1-vs-Grade 4
8.155500E-02
Grade 2-vs-Grade 3
4.191800E-01
Grade 2-vs-Grade 4
1.020220E-02
Grade 3-vs-Grade 4
2.097600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.983600E-02
Normal-vs-NonDiabetic
1.683980E-01
Diabetic-vs-NonDiabetic
2.384000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.784500E-02
Normal-vs-NoPancreatitis
1.359170E-01
Pancreatitis-vs-NoPancreatitis
1.854990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.640450E-01
Normal-vs-N1
9.497800E-02
N0-vs-N1
9.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.446000E-01
Normal-vs-TP53-NonMutant
4.242600E-01
TP53-Mutant-vs-TP53-NonMutant
8.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
